| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
| 1 | Adherens junction 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 2 | Adrenergic signaling in cardiomyocytes 5 genes, 1 drug (DrugBank) and 5 diseases shown |
5件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, SCN5A |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 3 | Alcoholism 6 genes, 3 drugs (DrugBank) and 15 diseases shown |
1件: DRD2 |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 4 | Aldosterone synthesis and secretion 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 6 | Allograft rejection 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 7 | Alzheimer disease 9 genes, 3 drugs (DrugBank) and 15 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 8 | Amphetamine addiction 11 genes, 3 drugs (DrugBank) and 15 diseases shown |
6件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 9 | AMPK signaling pathway 2 genes, 2 drugs (DrugBank) and 11 diseases shown |
1件: HMGCR |
D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 10 | Amyotrophic lateral sclerosis (ALS) 7 genes, 3 drugs (DrugBank) and 15 diseases shown |
2件: GRIA1, GRIA2 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 11 | Antigen processing and presentation 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 13 | Asthma 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 14 | Autoimmune thyroid disease 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 15 | Bile secretion 2 genes, 2 drugs (DrugBank) and 13 diseases shown |
1件: CA2 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: HMGCR |
D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| 16 | Calcium signaling pathway 9 genes, 4 drugs (DrugBank) and 18 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 4件: GRIN1, GRIN2A, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 1件: HTR2A |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 17 | cAMP signaling pathway 14 genes, 4 drugs (DrugBank) and 18 diseases shown |
8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: DRD2 |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 18 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: CACNA1D |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 19 | Cardiac muscle contraction 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 20 | Cell adhesion molecules (CAMs) 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 21 | Cellular senescence 7 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: CACNA1D |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 22 | cGMP-PKG signaling pathway 5 genes, 2 drugs (DrugBank) and 6 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 23 | Cholinergic synapse 5 genes, 2 drugs (DrugBank) and 12 diseases shown |
1件: ACHE |
D00670 |
Donepezil |
9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 |
| D07869 |
| 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 24 | Circadian entrainment 11 genes, 3 drugs (DrugBank) and 15 diseases shown |
6件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 25 | Cocaine addiction 7 genes, 4 drugs (DrugBank) and 18 diseases shown |
1件: DRD2 |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 1件: GRIA2 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 26 | Collecting duct acid secretion 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: CA2 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 27 | Cortisol synthesis and secretion 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 28 | Cushing syndrome 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 29 | Dilated cardiomyopathy (DCM) 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 30 | Dopaminergic synapse 10 genes, 4 drugs (DrugBank) and 18 diseases shown |
7件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, SCN1A |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: DRD2 |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 31 | Endocytosis 6 genes, 1 drug (DrugBank) and 4 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 32 | Epstein-Barr virus infection 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 33 | FoxO signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 1件: S1PR1 |
D10001 |
Fingolimod |
4件: 2, 13, 14, 156 |
| 34 | GABAergic synapse 20 genes, 1 drug (DrugBank) and 5 diseases shown |
20件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 35 | Gap junction 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: DRD2, HTR2A |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 36 | Gastric acid secretion 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: CA2 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 37 | Glutamatergic synapse 16 genes, 3 drugs (DrugBank) and 15 diseases shown |
11件: CACNA1C, CACNA1D, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 38 | Glycerophospholipid metabolism 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ACHE |
D00670 |
Donepezil |
9件: 5, 6, 13, 46, 78, 124, 127, 156, 206 |
| D07869 |
| 39 | GnRH secretion 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 40 | GnRH signaling pathway 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 41 | Graft-versus-host disease 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 42 | Growth hormone synthesis, secretion and action 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 43 | Hematopoietic cell lineage 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 44 | Herpes simplex virus 1 infection 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 45 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 46 | Human cytomegalovirus infection 6 genes, 1 drug (DrugBank) and 4 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 47 | Human immunodeficiency virus 1 infection 6 genes, 1 drug (DrugBank) and 4 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 48 | Human papillomavirus infection 6 genes, 1 drug (DrugBank) and 4 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 49 | Human T-cell leukemia virus 1 infection 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 50 | Huntington disease 2 genes, 2 drugs (DrugBank) and 12 diseases shown |
2件: GRIN1, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 51 | Hypertrophic cardiomyopathy (HCM) 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 52 | Inflammatory bowel disease (IBD) 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 53 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: HTR2A |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 54 | Influenza A 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 55 | Insulin resistance 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 56 | Insulin secretion 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 57 | Insulin signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 58 | Intestinal immune network for IgA production 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 59 | Kaposi sarcoma-associated herpesvirus infection 6 genes, 1 drug (DrugBank) and 4 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 60 | Leishmaniasis 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 61 | Long-term depression 3 genes, 1 drug (DrugBank) and 5 diseases shown |
3件: GRIA1, GRIA2, GRIA3 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 62 | Long-term potentiation 8 genes, 3 drugs (DrugBank) and 15 diseases shown |
3件: CACNA1C, GRIA1, GRIA2 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 63 | Longevity regulating pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 64 | Longevity regulating pathway - multiple species 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 65 | MAPK signaling pathway 5 genes, 2 drugs (DrugBank) and 6 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 66 | Metabolic pathways 3 genes, 2 drugs (DrugBank) and 13 diseases shown |
2件: CA2, CA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: HMGCR |
D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| 67 | Morphine addiction 16 genes, 1 drug (DrugBank) and 5 diseases shown |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 68 | mTOR signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 69 | Natural killer cell mediated cytotoxicity 5 genes, 1 drug (DrugBank) and 4 diseases shown |
5件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 70 | Neuroactive ligand-receptor interaction 33 genes, 5 drugs (DrugBank) and 19 diseases shown |
2件: DRD2, HTR2A |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 25件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 1件: S1PR1 |
D10001 |
Fingolimod |
4件: 2, 13, 14, 156 |
| 71 | Nicotine addiction 25 genes, 3 drugs (DrugBank) and 15 diseases shown |
20件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 72 | Nitrogen metabolism 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: CA2, CA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 73 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 74 | Ovarian steroidogenesis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 75 | Oxytocin signaling pathway 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 76 | Pancreatic secretion 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: CA2 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 77 | Parkinson disease 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: DRD2 |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 78 | Phagosome 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 79 | Phospholipase D signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 80 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 81 | Proximal tubule bicarbonate reclamation 2 genes, 1 drug (DrugBank) and 5 diseases shown |
2件: CA2, CA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 82 | Rap1 signaling pathway 5 genes, 4 drugs (DrugBank) and 15 diseases shown |
1件: DRD2 |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 83 | Ras signaling pathway 4 genes, 3 drugs (DrugBank) and 12 diseases shown |
3件: GRIN1, GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 84 | Regulation of lipolysis in adipocytes 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 85 | Renin secretion 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 86 | Retrograde endocannabinoid signaling 24 genes, 1 drug (DrugBank) and 5 diseases shown |
24件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 87 | Rheumatoid arthritis 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 88 | Serotonergic synapse 9 genes, 3 drugs (DrugBank) and 10 diseases shown |
7件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRB1, GABRB2, GABRB3 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: HTR2A |
D00426 |
Risperidone |
5件: 8, 156, 179, 187, 206 |
| 1件: SLC6A4 |
D00812 |
Desipramine |
2件: 120, 156 |
| D07791 |
| 89 | Sphingolipid signaling pathway 1 gene, 1 drug (DrugBank) and 4 diseases shown |
1件: S1PR1 |
D10001 |
Fingolimod |
4件: 2, 13, 14, 156 |
| 90 | Staphylococcus aureus infection 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 91 | Synaptic vesicle cycle 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: SLC6A2, SLC6A4 |
D00812 |
Desipramine |
2件: 120, 156 |
| D07791 |
| 92 | Systemic lupus erythematosus 16 genes, 3 drugs (DrugBank) and 12 diseases shown |
2件: GRIN2A, GRIN2B |
D00848 |
Dextromethorphan |
9件: 2, 6, 8, 13, 46, 78, 96, 97, 156 |
| D03742 |
| D03744 |
| D00711 |
Ketamine |
6件: 6, 13, 70, 113, 156, 215 |
| D08098 |
| 14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 93 | Taste transduction 10 genes, 1 drug (DrugBank) and 5 diseases shown |
10件: CACNA1C, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, SCN2A, SCN3A, SCN9A |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 94 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank) and 10 diseases shown |
1件: HMGCR |
D00359 |
Lovastatin |
10件: 6, 34, 46, 79, 156, 160, 195, 206, 263, 310 |
| 95 | Th1 and Th2 cell differentiation 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 96 | Th17 cell differentiation 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 97 | Tight junction 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: CACNA1D |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 98 | Toxoplasmosis 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 99 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank) and 5 diseases shown |
1件: GRIA3 |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 100 | Tuberculosis 14 genes, 1 drug (DrugBank) and 4 diseases shown |
14件: HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5 |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 101 | Type I diabetes mellitus 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 102 | Type II diabetes mellitus 3 genes, 2 drugs (DrugBank) and 6 diseases shown |
2件: CACNA1C, CACNA1D |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 1件: INSR |
D00085 |
Insulin Human |
2件: 96, 156 |
| D03230 |
| 103 | Vascular smooth muscle contraction 4 genes, 1 drug (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00537 |
Topiramate |
5件: 6, 140, 144, 156, 193 |
| 104 | Viral carcinogenesis 6 genes, 1 drug (DrugBank) and 4 diseases shown |
6件: HLA-A, HLA-B, HLA-C, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |
| 105 | Viral myocarditis 20 genes, 1 drug (DrugBank) and 4 diseases shown |
20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G |
D04318 |
Glatiramer |
4件: 2, 13, 96, 156 |